Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types

14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types

US Patent 7316907 · Granted Jan 8, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IGBT chip integrating temperature sensor2025
DrMOS, integrated circuit, electronic device, and preparation method2025
Graphene thermally conductive gasket edge-wrapped process and edge-wrapped graph2024
Automatic leveling control method for a four-leg support working platform2024
Landslide hazard monitoring and early warning method and system based on real 3D2024
Full-bore indefinite-level staged fracturing sliding sleeve based on smart label2024
Leveling control method for multi-point support platform2024
Speaker module and portable electronic device2024
Methods for selecting antibodies that specifically bind glycosylated immune chec2024
Method for printing silver nanowire harness network structure by using glue disp2024
Method for improving the colour difference of LED display screen2024
Lunch box2024